Calendar

pharmadog

Week of Mar 2, 2026

Mar 4, 2026approval164d agoBAL (DIMERCAPROL) — FDA approvalAkorn Operating Company LLC (Inactive)

Sponsor: PROVEPHARM SAS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 4, 2026approval164d agoROCURONIUM BROMIDE — FDA approvalROCURONIUM BROMIDE

Sponsor: ASPIRO. Form: INJECTABLE. Route: INJECTION

full page →ROCURONIUM BROMIDE →fda approvals ↗

Mar 4, 2026approval164d agoEMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE) — FDA approvalHetero USA Inc

Sponsor: LAURUS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 4, 2026approval164d agoCALCITONIN-SALMON (CALCITONIN SALMON) — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 4, 2026approval164d agoDESIPRAMINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS CO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 4, 2026approval164d agoGLIPIZIDE — FDA approvalGraviti Pharmaceuticals Inc

Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 5, 2026approval163d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalPrinston Pharmaceutical Inc

Sponsor: TEVA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 5, 2026approval163d agoCHOLESTYRAMINE — FDA approvalCHOLESTYRAMINE

Sponsor: MICRO LABS. Form: POWDER. Route: ORAL

full page →CHOLESTYRAMINE →fda approvals ↗

Mar 5, 2026approval163d agoIBUPROFEN — FDA approvalMidol

Sponsor: RUBICON RESEARCH. Form: SUSPENSION. Route: ORAL

full page →Midol →fda approvals ↗

Mar 5, 2026approval163d agoTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalteclistamab

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →teclistamab →fda approvals ↗

Mar 5, 2026approval163d agoTALVEY (TALQUETAMAB-TGVS) — FDA approvaltalquetamab

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →talquetamab →fda approvals ↗

Mar 5, 2026approval163d agoOLANZAPINE — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

Sponsor: ANTHEA PHARMA. Form: POWDER. Route: INTRAMUSCULAR

full page →fda approvals ↗

Mar 5, 2026approval163d agoAPREPITANT — FDA approvalAPREPITANT

Sponsor: MYLAN. Form: EMULSION. Route: INTRAVENOUS

full page →APREPITANT →fda approvals ↗

Mar 5, 2026approval163d agoCHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE) — FDA approvalAlgoTherapeutix SAS

Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 5, 2026approval163d agoCHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE) — FDA approvalAlgoTherapeutix SAS

Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 5, 2026approval163d agoXYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approvalSanofi

Sponsor: CHATTEM SANOFI. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Mar 5, 2026approval163d agoKEFLEX (CEPHALEXIN) — FDA approvalBelcher Pharmaceuticals LLC

Sponsor: PRAGMA. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Mar 5, 2026approval163d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Mar 5, 2026approval163d agoERLEADA (APALUTAMIDE) — FDA approvalapalutamide

Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL

full page →apalutamide →fda approvals ↗

Mar 5, 2026approval163d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: ANNORA PHARMA. Form: SUSPENSION. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

Mar 6, 2026approval162d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

full page →risankizumab →fda approvals ↗

Mar 6, 2026approval162d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION

full page →risankizumab →fda approvals ↗

Mar 6, 2026approval162d agoQUDEXY XR (TOPIRAMATE) — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoPYLARIFY TRUVU (PIFLUFOLASTAT F-18) — FDA approval

Sponsor: APHELION. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

full page →Restasis →fda approvals ↗

Mar 6, 2026approval162d agoQSYMIA (PHENTERMINE HYDROCHLORIDE) — FDA approval(phentermine hydrochloride + topiramate) ER

Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →(phentermine hydrochloride + topiramate) ER →fda approvals ↗

Mar 6, 2026approval162d agoTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoXELJANZ XR (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Mar 6, 2026approval162d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvalBiocon Pharma Ltd

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Mar 6, 2026approval162d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Mar 6, 2026approval162d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoSIPONIMOD — FDA approvalSIPONIMOD

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →SIPONIMOD →fda approvals ↗

Mar 6, 2026approval162d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Mar 6, 2026approval162d agoSOTYKTU (DEUCRAVACITINIB) — FDA approvalBristol-Myers Squibb Co

Sponsor: BRISTOL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoTROKENDI XR (TOPIRAMATE) — FDA approvalSUPERNUS PHARMACEUTICALS, INC.

Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoNICARDIPINE HYDROCHLORIDE — FDA approvalNICARDIPINE HYDROCHLORIDE

Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

full page →NICARDIPINE HYDROCHLORIDE →fda approvals ↗

Mar 6, 2026approval162d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: PRINSTON INC. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Mar 6, 2026approval162d agoEVEROLIMUS — FDA approvalEVEROLIMUS

Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

full page →EVEROLIMUS →fda approvals ↗

Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION

full page →Restasis →fda approvals ↗

Mar 6, 2026approval162d agoEPRONTIA (TOPIRAMATE) — FDA approvaltopiramate ER

Sponsor: AZURITY. Form: SOLUTION. Route: ORAL

full page →topiramate ER →fda approvals ↗

Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL

full page →Restasis →fda approvals ↗

Mar 6, 2026approval162d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

Sponsor: PFIZER. Form: SOLUTION. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Week of Mar 9, 2026

Mar 9, 2026approval159d agoOXCARBAZEPINE — FDA approvalRiconpharma LLC

Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

Mar 9, 2026approval

← prev

page 1 of 11

Week of Mar 2, 2026

Week of Mar 9, 2026